StockData
PTIXOTCPharmaceutical PreparationsFiscal year ends March 31

Protagenic Therapeutics, Inc.\new

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$1.36M
P/E (TTM)
–
Dividend yield
–

Protagenic Therapeutics, Inc.\new revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Protagenic Therapeutics, Inc.\new does not break out revenue by segment, region or product in the tagged data of its filings for this period type.